Phase 4 Fibromyalgia Trial, Recruiting NCT07082972 Sponsor: Istanbul University Condition: Fibromyalgia
Back to Fibromyalgia

Phase 4 Fibromyalgia Trial, Recruiting

NCT07082972
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with myofascial pain syndrome (a condition involving pain in the muscles)
  • People who have all of their natural teeth, with none missing
  • People who have not previously received any treatment for jaw joint or jaw muscle disorders
  • People whose jaw-related pain comes from the muscles only, not from a structural problem with the jaw joint itself

Who may not be able to join:

  • People who are pregnant or breastfeeding, or who have osteoporosis and are taking bisphosphonate medications for it
  • People who have previously had botulinum toxin (such as Botox) injected into the jaw muscle area
  • People who have a bleeding disorder or who take blood-thinning medications
  • People who have a systemic muscle or nerve condition, such as myasthenia gravis or ALS (motor neurone disease)
  • People who have an active infection, an open wound, or a skin condition affecting the face
  • People who have had a facial aesthetic procedure — such as fillers or PRP — within the past six months
  • People who have a severe psychiatric (mental health) condition or who regularly take psychiatric medications
  • People who are unlikely to follow the study procedures or attend all required follow-up appointments
  • People whose body mass index (BMI) falls outside the normal healthy range, including those considered underweight or overweight

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Olcay Şakar, Phd Prof., Istanbul University

Phone: +905398757502

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Istanbul University
Registry
ClinicalTrials.gov
Start date
1 September 2025
Est. completion
1 September 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Electromyography results

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov